Last reviewed · How we verify

NCT03880552

Perineal Body Length and Perineal Lacerations

Completed Last updated 14 August 2019
What this trial tests

trial testing Primigravid women with singleton pregnancy at 35th week over in Perineal Laceration Involving Skin in 300 participants. Completed in 1 June 2019.

Timeline
1 December 2018
Primary endpoint
1 June 2019
1 June 2019

Quick facts

Lead sponsorKanuni Sultan Suleyman Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date1 December 2018
Primary completion1 June 2019
Estimated completion1 June 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 18 to 40, female only, with Perineal Laceration Involving Skin or Delivery; Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate the relationship between perineal body length and perineal laceration risk in primigravid patients. Primigravid women with singleton pregnancies in the first stage of labor at the 35th week of gestation were included in the study. The peineal body length of the patients was measured by the same physician.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03880552.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing